Related references
Note: Only part of the references are listed.RELATIONSHIP BETWEEN CHOROIDAL VASCULAR HYPERPERMEABILITY, CHORIOCAPILLARIS FLOW DENSITY, AND CHOROIDAL THICKNESS IN EYES WITH PACHYCHOROID PIGMENT EPITHELIOPATHY
Yoichi Sakurada et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2020)
Discrepancy in current central serous chorioretinopathy classification
Sumit Randhir Singh et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3
Thomas J. Van Rijssen et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)
Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage
Thomas J. van Rijssen et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
Central serous chorioretinopathy: Towards an evidence-based treatment guideline
Thomas J. van Rijssen et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2019)
Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy
Sarah Mrejen et al.
OPHTHALMOLOGY (2019)
Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
Thomas J. van Rijssen et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2018)
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy The PLACE Trial
Elon H. C. van Dijk et al.
OPHTHALMOLOGY (2018)
Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy
Thomas J. van Rijssen et al.
PLOS ONE (2018)
Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life
Myrte B. Breukink et al.
CLINICAL OPHTHALMOLOGY (2017)
A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
Frank H. P. Lai et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
One-Year Outcomes with Half-Dose Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Kyoko Fujita et al.
OPHTHALMOLOGY (2015)
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
Alejandra Daruich et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2015)
Collaborative Retrospective Macula Society Study of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Jennifer I. Lim et al.
OPHTHALMOLOGY (2014)
Fundus Autofluorescence and Visual Acuity in Central Serous Chorioretinopathy
Yutaka Imamura et al.
OPHTHALMOLOGY (2011)
The Cone-specific visual cycle
Jin-Shan Wang et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2011)
The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy
FC Piccolino et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Risk factors for central serous chorioretinopathy - A case-control study
R Haimovici et al.
OPHTHALMOLOGY (2004)
Share Paper
